NASDAQ: RYM

RYTHM has also historically
been a leading provider of innovative cultivation and extraction solutions for the cannabis industry. Prior to the exit of the extraction
business on March 30, 2025, the Company’s comprehensive extraction product line (“the Extraction Business”), which
included hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowered cannabis producers to maximize the quantity
and quality of extract required for premium concentrates. Additionally, prior to its sale on December 31, 2024, the Company’s proprietary
micro-environment-controlled Agrify Vertical Farming Units (“VFUs”) enabled cultivators to produce high quality products
for the cannabis industry.

Recent Developments

Name Change

Following our acquisition
of VCP IP Holdings, LLC and the RYTHM brand, we changed our name from Agrify Corporation to RYTHM, Inc. effective as of September
2, 2025, and changed our ticker symbol on the Nasdaq Capital Market from AGFY to RYM effective as of the market open on that date.

Convertible Note Issuances

On November 5, 2024, we
issued a Secured Convertible Note (the “November 2024 Note”) with an original principal amount of $10.0 million to
RSLGH, LLC (“RSLGH”), a subsidiary of Green Thumb Industries Inc. (“Green Thumb”), a related party. On
November 3, 2025, RSLGH elected to convert the outstanding principal and interest through November 3, 2025, into pre-funded warrants
subject to a 49.99% beneficial ownership limitation and any required approval of stockholders under Nasdaq listing rules. The
outstanding principal and accrued interest amounts of $10 million and $175 thousand respectively, resulted in the issuance of
3,167,564 and 55,433 pre-funded warrants, respectively. Each pre-funded warrant represents the right to acquire one share of our
common stock.

On May 22, 2025, we issued
Secured Convertible Notes with an aggregate original principal amount of $30.0 million (the “May 2025 Notes”) to RSLGH and
to certain other accredited investors. The May 2025 Notes mature on November 22, 2026 and are convertible into shares of common stock
or, at the holder’s election, pre-funded warrants, at a conversion price of $23.53, subject to a 49.99% beneficial ownership limitation
for RSLGH, a 4.99% beneficial ownership limitation for the other holders, and any required approval of stockholders under Nasdaq listing
rules.

On August 25, 2025, we issued
Secured Convertible Notes with an aggregate original principal amount of $50.0 million (the “August 2025 Notes” and, collectively
with the November 2024 Note and the May 2025 Notes, the “Notes”) to RSLGH and to certain other accredited investors. The
August 2025 Notes will mature on February 25, 2027 and are convertible into shares of common stock or, at the holder’s election,
pre-funded warrants, at a conversion price of $29.475, subject to a 49.99% beneficial ownership limitation for RSLGH, a 4.99% beneficial
ownership limitation for the other holders, and any required approval of stockholders under Nasdaq listing rules.

1

Each Note is a secured obligation
and ranks senior to all of our indebtedness except for the other Notes. Each Note accrues interest at a 10.0% annualized rate, with interest
to be paid on the first calendar day of each September and March while the Note is outstanding, which may be paid in the form of pre-funded
warrants or, in the case of the August 2025 Notes and at the election of the holders of a majority of the August 2025 Notes, cash or
common stock, subject to any applicable Nasdaq restrictions. The principal amount of each Note will be payable on its applicable maturity
date.

The Notes impose certain
customary affirmative and negative covenants upon us. If an event of default under a Note occurs, the holder can elect to redeem the
Note for cash equal to the then-outstanding principal amount of the Note (or such lesser principal amount accelerated by the applicable
holder), plus accrued and unpaid interest, including default interest, which accrues at a rate per annum equal to 14% from the date of
a default or event of default.

Shared Services Agreements

On May 20, 2025, we entered
into an Amended and Restated Shared Services Agreement (the “Services Agreement”) with Vision Management Services, LLC (“VMS”),
an indirect wholly-owned subsidiary of Green Thumb, a related party. Under the Services Agreement, VMS provides certain administrative,
supply chain, operations management, sales and marketing, and technical services to us and our subsidiaries. As consideration for those
services, we pay VMS service fees equal to (i) 125% of the costs incurred by VMS in connection with any services provided by non-dedicated
personnel, including the applicable portion of salary, bonus, equity compensation cost, health care and other benefits, and (ii) 100%
of such costs incurred by VMS in connection with services provided by dedicated personnel and any third-party costs incurred in connection
with the services. The service fees are payable in cash or, upon mutual agreement of us and VMS and to the extent permitted under applicable
Nasdaq listing rules, in common stock or in pre-funded warrants, with the value per share of common stock or pre-funded warrant being
equal to $26.68. The maximum cost for services provided by non-dedicated personnel during the one-year term of the Services Agreement
may not exceed $3.0 million unless the parties otherwise agree in writing. The Services Agreement is for a term of one year, is terminable
by either party on 90 days’ notice for any or no reason, and will automatically renew for successive one-year terms unless terminated
by either party at least thirty days prior to the end of the applicable term.

On March 21, 2025, we entered
into a Shared Services Agreement (the “CFO Services Agreement”) with VMS, pursuant to which Brad Asher provides his services
as Chief Financial Officer. As consideration for those services, we pay VMS a monthly fee based on its direct costs in providing such
services, with a maximum of $72,552 per month. The CFO Services Agreement has a term of one year, is terminable by either party on 90
days’ notice for any or no reason, and will automatically renew for successive one year terms unless terminated by either party
at least thirty days prior to the end of the applicable term. As a result of the services provided under the Services Agreement and the
CFO Services Agreement, we do not have any direct employees other than our Interim Chief Executive Officer.

Licensing Revenue

On May 20, 2025, we acquired
from VCP IP Holdings, LLC (“VCP”) an indirect wholly-owned subsidiary of Green Thumb, a related party, 100% of the equity
interests of MC Brands, LLC pursuant to which we obtained rights relating to MC Brands, LLC and its wholly-owned subsidiary Core Growth
LLC (together referred to as “MC Brands”) the assets of which consist primarily of intellectual property rights to the incredibles
brand. Concurrent with the transaction, we entered into a license agreement with GTI Core, LLC, (“GTI Core”), an indirect
subsidiary of Green Thumb, pursuant to which GTI Core was granted the right to use the incredibles brand in connection with its existing
businesses. Consideration payable by GTI Core under the license agreement consists of a monthly license fee payable in cash. We began
recognizing licensing revenue under this agreement in May 2025.

On August 27, 2025, we acquired
from VCP23, LLC an indirect wholly-owned subsidiary of Green Thumb, 100% of the equity interests of VCP IP Holdings, LLC pursuant to which
we obtained rights relating to VCP IP Holdings, LLC, the assets of which consist primarily of intellectual property
rights to the RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, & Shine, and Good Green brands (these rights, together with the incredibles
brand rights, referred to as “Brand Rights”). Concurrent with the transaction, we entered into a license agreement with GTI
Core pursuant to which GTI Core was granted the right to use the Brand Rights in connection with its existing businesses. Consideration
payable by GTI Core under the license agreement consists of a monthly license fee payable in cash. We began recognizing licensing revenue
under this agreement in November 2025. The MC Brands and VCP purchase agreements also granted Green Thumb or its affiliates certain repurchase
rights, which may be triggered by events outside of the control of Green Thumb and the Company.

2

Hemp-Derived Products

We acquired the
Señorita brand of hemp-derived THC beverages in December 2024. Señorita was designed and formulated by world-class
winemakers Charles Bieler and Joel Gott. Recognizing a growing generational demand for adult beverage alternatives, Mr. Bieler and
Mr. Gott gave the classic margarita a modern twist—replacing alcohol with hemp-derived THC to create a delightful adult
beverage alternative. Through the use of all-natural, premium ingredients like organic Mexican agave, fresh lime juice and sweet,
tangy mango, Señorita quickly gained acclaim, taking home the top spot in The High Times Cannabis Cup just one year after
inception. Mr. Gott and Mr. Bieler continue to collaborate on the brand with Mr. Kovler and the RYTHM team.

Señorita currently
offers four award-winning flavors – classic Lime Jalapeño Margarita, Paloma, Mango Margarita, and Ranch Water. Señorita’s
hemp-derived beverages are currently available at top retailers including Total Wine, ABC Fine Wine & Spirits, and Binny’s
in fifteen U.S. states and Canada. Products are also available for direct-to-consumer purchase where permissible under state law at senoritadrinks.com.

The Company’s portfolio
of consumer-packaged goods brands includes RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, Good Green and
Señorita. The RYTHM and Señorita brands offer consumers hemp-derived THC beverages and are sold at top retailers, online
and through direct-to-retail partnerships. The Señorita brand mirrors well-known cocktails like a margarita in four flavors and
the RYTHM branded beverage comes in two fruit-driven flavors with effect-based ingredients. Other hemp-derived products including incredibles
and Beboe edible products are primarily sold online and through direct-to-retail partnerships.

Co-Manufacturing Arrangements

Our finished goods are manufactured
by various third-party co-manufacturers situated throughout the United States and Canada, under separate arrangements with each party.
Our co-manufacturing arrangements vary in terms and, from time to time, we may enter into manufacturing contracts with agreed upon minimum
quantities to ensure continuity of supply of certain products in certain territories. We continue to actively seek alternative and/or
additional co-manufacturing facilities with adequate capacity and capability for the production of our various products to minimize transportation
costs as well as mitigate the risk of disruption in production.

Our ability to estimate
demand for our products is imprecise, particularly with new products, and may be less precise during periods of rapid growth or regulatory
uncertainty which is currently common in our industry. If we materially underestimate demand for our products and/or are unable to secure
sufficient ingredients or raw materials and/or procure adequate co-manufacturing arrangements and/or obtain adequate or timely shipment
of our products, we might not be able to satisfy demand on a short-term basis. Conversely, if demand for our products declines or does
not materialize as expected, including due to regulatory uncertainty or changes in applicable laws or regulations, we may accumulate
excess inventory, which could lead to inventory obsolescence, write-downs, or reduced margins.

Distribution Agreements

During 2025 we continued to expand distribution
of our hemp-derived products in our domestic markets. We have entered into agreements with various distributors providing for the distribution
of certain of our hemp-derived products, subject to certain terms and conditions, which may vary depending on the form of the agreement.
Such agreements remain in effect for their then-current term as long as our products are being distributed, but are subject to specified
termination rights held by each party. Additionally, we are entitled to terminate certain distribution agreements at any time without
cause upon payment of a termination fee, which may be material depending on the agreement.

3

Discontinued Operations

Cultivation Solutions

Prior to its sale on December
31, 2024, we sold proprietary cultivation solutions to independent licensed cultivators as part of our Cultivation Business. The two
primary products we sold were the VFUs and Agrify Insights™ software. The proprietary VFU technology offered a modular, compartmentalized
micro-climate growing system for indoor vertical farming. The VFU system was designed for craft farmers, single-state operators, and
multi-state operators who were looking to consistently produce higher-quality crops at scale. The VFUs were designed to line up horizontally
in rows, and could be stacked vertically up to three units tall. The VFUs were designed to work in conjunction with the Agrify Insights™
software. Each VFU sold included a license for Agrify Insights™ and a monthly Software-as-a-Service (“SaaS”) subscription
fee was charged per VFU. The VFU could not operate successfully without Agrify Insights™. Agrify Insights™ license agreements
were generally for a multi-year term, with an annual auto-renewal.

Extraction Solutions

Prior to its discontinuation
on March 30, 2025, our extraction equipment and business solutions that were a part of our Extraction Business could be used within indoor
processing facilities by fully licensed cannabis and hemp cultivators and processors or in some cases, by individual processors for individual
use in compliance with applicable law. We sold our proprietary extraction solutions to independent, licensed cultivators and processing
labs. We had strategically acquired four brands in the extraction space in late 2021 and early 2022: Precision Extraction, PurePressure,
Lab Society, and Cascade Sciences. These brands encompassed hydrocarbon, alcohol, and solventless extraction and distillation and post-processing
solutions. Our extraction brands provided equipment and solutions for extraction, post-processing, and testing for the cannabis and hemp
industries.

Regulatory Landscape Overview

The regulatory
landscape for products infused with hemp-derived delta-9 tetrahydrocannabinol and other cannabinoids with intoxicating effects
(collectively “hemp-derived THC”) is a source of material risk for the Company. While the 2018 Farm Bill (defined below)
both defined and legalized hemp under federal law, the subsequent use of hemp to make THC consumer products was reportedly not
anticipated by legislators. Those products are similar in composition to certain state-legal and federally illegal cannabis consumer
products, but are not controlled substances and thus can be shipped via interstate commerce. Their legal status at the federal level
also means that they generally do not fall under the same state regulatory schemes or have the same heavy tax burdens that state
legal cannabis products do. As the industry expanded, lawmakers at the state level have begun to regulate such products, including
with age limits and manufacturing standards; however, some states have instead passed laws restricting or prohibiting hemp-derived
THC products due to concerns raised by federal, state, and local lawmakers about minors’ access to some of these products,
inadequate testing, and other public health concerns.

Passed on November 12, 2025,
the Continuing Appropriations and Extensions Act of 2026 (H.R. 5371) (the “2026 Appropriations Act”) includes a provision
(section 781) to amend the definition of hemp in the Agricultural Improvement Act of 2018 (the “2018 Farm Bill”) to effectively
prohibit the currently commercialized hemp-derived THC products, including the Company’s products, although the change does not
become effective for 365 days from the date of enactment. Efforts are underway to repeal, replace, or delay this amendment, but whether
any change will occur is uncertain. If this provision of the 2026 Appropriations Act is not repealed, replaced or delayed by its effective
date, we will not be able to sell our current line of hemp-derived THC products. In addition, this would meet one of the eligibility conditions that would permit the repurchase right to become
exercisable under the MC Brands and VCP purchase agreements. However, satisfaction of such conditions would not obligate Green Thumb or
its affiliates to exercise the repurchase option, which remains within their discretion.

On December 18, 2025, President Trump issued
an Executive Order directing that cannabis be rescheduled from Schedule I to Schedule III (which we refer to as “rescheduling”).
The Order directs the Attorney General to “take all necessary steps to complete the rulemaking process related to rescheduling
marijuana to Schedule III of the Controlled Substances Act in the most expeditious manner.” A rescheduling may have far reaching
implications that are not yet fully understood, including potentially for hemp and hemp products. The Executive Order also discussed
a newly proposed pilot program where CMS (Centers for Medicare & Medicaid Services), through CMMI (Center for Medicare & Medicaid
Innovation), will be able to cover the costs for certain cannabinoid based hemp therapies for seniors. Additional details for this program
and its requirements are still pending, and it is uncertain whether the Company would be able to participate or whether the pilot program
will drive additional competition from the pharmaceutical or other industries. Such other companies may have a longer operating history,
a higher capitalization, additional financial resources, more manufacturing and marketing experience, greater access to public equity
and debt markets and more experienced management than the Company. In addition to the pilot program, the Executive Order directs White
House staff to work with Congress to “update the statutory definition” of hemp to allow Americans to access cannabidiol (“CBD”)
products while permitting Congress to “restrict the sale of products posing serious health risks,” and to consult with relevant
executive branch departments to “develop a regulatory framework for hemp-derived cannabinoid products, including development of
guidance on an upper limit on milligrams of THC per serving with considerations on per container limits and CBD to THC ratio requirements.”
It is unclear how this will be achieved, and whether Congress—which just revised the definition of hemp in the 2026 Appropriations
Act—will agree to further changes. All of this regulatory volatility creates significant uncertainty for our business of selling
hemp-derived THC products.

4

Competitive Landscape Overview

The U.S. cannabis and cannabis-related
industries are, and are expected to continue to be, competitive. A number of other companies engage in, and may in the future engage
in, cannabis-related businesses, operate businesses in competition with us and purchase businesses and assets or make investments that
we will also seek to purchase or make. We face and expect to continue to face competition from state-licensed medical and adult-use dispensaries.

Large chain stores, manufacturers,
retailers, beverage and other consumer products companies that also recognize the potential for financial success through acquisitions
and investment in the hemp-derived THC beverage industry could strategically acquire competitors or invest in creating their own brands.
In doing so, these larger competitors could produce and sell competing products at a lower price and establish a larger brand presence.
We may not have the personnel, products, marketing and distribution capabilities, and/or financial resources to compete effectively against
such larger competitors.

We also face competition
from the illicit market and illegal dispensaries and cultivation operations that are unlicensed, not regulated and that are selling cannabis
or hemp-derived THC products. Any inability or unwillingness of law enforcement authorities to enforce existing laws prohibiting the
unlicensed production and sale of cannabis or hemp-derived THC products could result in increased competition for us.

Intellectual Property

We rely on a combination
of patent, trademark, copyright, and trade secrets, including federal, state and common law rights in the U.S. and other countries, nondisclosure
agreements, and other measures to protect our intellectual property. We require our employees, consultants, and advisors to execute confidentiality
agreements and to agree to disclose and assign to us all inventions conceived under their respective employment, consultant, or advisor
agreement, using our property, or which relate to our business. Despite any measures taken to protect our intellectual property, unauthorized
parties may attempt to copy aspects of our products or to obtain and use information that we regard as proprietary. Our business, including
the revenue we recognize through licensing our brands, is affected by our ability to protect against misappropriation and infringement of
our intellectual property, including our trademarks, service marks, patents, domain names, copyrights, brand rights, Prepaid License Rights and other proprietary rights.

Human Capital Resources

As of March 3, 2026, our human capital resources are predominantly
provided pursuant to shared services agreements with Green Thumb, which are largely focused on sales and marketing functions. As of that
date, we had one employee and approximately 50 dedicated consultants.

Environmental Regulations

We are not aware of any
environmental laws that have been enacted, nor are we aware of any such laws being contemplated for the future, that have or would be
expected to have a material impact on our business.

Implications of Being a Smaller Reporting Company

Because the market value
of our voting and non-voting common stock held by non-affiliates was less than $700 million measured on the last business day of our
second fiscal quarter and our annual revenue was less than $100 million during the most recently completed fiscal year prior to such
date, we qualify as a “smaller reporting company” as defined in the Securities Exchange Act of 1934, as amended, or the Exchange
Act. We may continue to be a smaller reporting company if either (i) the market value of our shares held by non-affiliates is less than
$250 million or (ii) the market value of our shares held by non-affiliates is less than $700 million and our annual revenue was less
than $100 million during the most recently completed fiscal year prior to the determination date. As a smaller reporting company, we
may provide less public disclosure than larger public companies, including the inclusion of only two years of audited financial statements
and only two years of related management’s discussion and analysis of financial condition and results of operations disclosure.
While we are a smaller reporting company, we are also not required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act as long as we are considered a non-accelerated filer or our annual revenues are less than $100 million. As
a result, the information that we provide to our stockholders may be different than what you might receive from other public reporting
companies in which you hold equity interests. We cannot predict if investors will find our common stock less attractive as a result of
our reliance on these exemptions. If some investors find our common stock less attractive as a result of any choice we make to reduce
disclosure, there may be a less active trading market for our common stock and the market price for our common stock may be more volatile.

5

Corporate Information

RYTHM, Inc. was incorporated
in the state of Nevada on June 6, 2016, originally incorporated as Agrinamics, Inc. (or Agrinamics). On September 16, 2019, Agrinamics
amended its articles of incorporation to reflect a name change to Agrify Corporation. On September 2, 2025, Agrify Corporation amended
its articles of incorporation to reflect a name change to RYTHM, Inc. Our executive offices are located at 2220 Hicks Road, Suite 210,
Rolling Meadows, Illinois 60008. Our telephone number at our executive offices is (855) 420-0020. Our website address is www.rythminc.com.

Available Information

Our Annual Reports on Form
10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d)
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are filed with the SEC. We are subject to the informational
requirements of the Exchange Act and file or furnish reports, proxy statements and other information with the SEC. Such reports and other
information filed by us with the SEC are available free of charge at https://ir.rythminc.com/financials-and-filings/sec-filings when
such reports are available on the SEC’s website. The SEC maintains an Internet site that contains reports, proxy and information
statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov. We periodically provide other
information for investors on our corporate website, www.rythminc.com, and our investor relations website, https://ir.rythminc.com. This
includes press releases and other information about financial performance, information on corporate governance and details related to
our annual meeting of shareholders. The information contained on the websites referenced in this Form 10-K is not incorporated by reference
into this filing. Further, our references to website URLs are intended to be inactive textual references only.